Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented final first-in-human data for ...
Primary results from the Phase II ARACOG (AFT-47) trial, a head-to-head randomized trial conducted by Alliance Foundation Trials LLC, showed that patients treated with NUBEQA ® (darolutamide; n=55) ...
The Canadian Press on MSN
Canada's Auger-Aliassime advances, Mboko ousted at French Open
PARIS — ...
Discover the essential techniques for validating and cleaning JSON data, ensuring data integrity and proper formatting for various applications and APIs.
There was plenty to ponder from Scotland's 4-1 win over 10-man Curacao at Hampden on Saturday, in what was their send-off ...
New research shows a novel pill is helping people with advanced pancreatic cancer live longer. It's not a cure, as the drug's effects eventually waned. But it's a very different ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results